Our coverage of PreveCeutical Medical (PRVCF) is updated with comments on recent progress with the Company’s portfolio of research and development projects focused on preventative therapeutics. The Company has several major achievements in recent months, moving the R&D pipeline closer to goals. In March 2018, the Company’s research and development partner UniQuest Pty. Ltd. began […]
Author: Crystal Equity Research
New Coverage – Westwater Resources (WWR)
We initiated coverage of Westwater Resources with a Speculative Buy rating and a one-year target price of $1.50 based on an estimated intrinsic value of $5.00 per share and tempered by recent trading patterns. Westwater is a building portfolio of energy materials assets that creates a triple threat of uranium, lithium and now graphite. The […]
New Coverage – PreveCeutical Medical (PRVCF)
PreveCeutical Medical is biomedical company focused on preventative health sciences using organic and nature-identical compounds. The Company was recently organized to pursue market opportunities for a novel therapy based on blue scorpion venom. PreveCeutical markets an CELLB9, an oral solution of blue scorpion venom for use without prescription. The solution has been found instrumental in […]
Updated Coverage – Moxian, Inc. (MOXC)
Our coverage is updated of Moxian, Inc., the most recent entrant into China’s thriving online-to-offline e-commerce market. Following report of quarter financial results, we spoke at length with Moxian’s chief executive officer James Mengdong Tan regarding the Company’s plans for market penetration and recent strategic developments. The group has shifted its approach to bring the […]
Update Report – Moxian, Inc. (MOXC)
Moxian has developed a proprietary online-to-offline ecommerce platform designed to enable small- and medium-sized business with local stores to reach customers via the Internet. In late 2016, the Company launched its Moxian+ platform in four major metropolitan areas in China and deployed sales teams to sign up interested merchants. We continue to view MOXC as […]